LAVA Therapeutics NV banner

LAVA Therapeutics NV
F:4PKB

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
F:4PKB
Watchlist
Price: 1.44 EUR Market Closed
Market Cap: €37.9m

Wall St Price Targets

4PKB Price Targets Summary
LAVA Therapeutics NV

There are no price targets for 4PKB.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
LAVA Therapeutics NV Competitors:
Price Targets
NWSA
News Corp
17% Upside
CRPR
James Cropper PLC
10% Upside
MRVL
Marvell Technology Group Ltd
24% Upside
TTD
Trade Desk Inc
16% Upside

Revenue
Forecast

36% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
36% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Over the last 4 years, the compound annual growth rate for Revenue has been 36%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 4PKB's stock price target?
Not Available

4PKB does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett